Clinical and laboratory findings in TTP2-7,12
. | Frequency (%) . |
---|---|
Clinical presentation, % | |
MAHA with thrombocytopenia | 100 |
Neurological abnormalities | 39-80 |
Major | 18-53 |
Minor | 27-42 |
Fever | 10-72 |
Gastrointestinal symptoms | 35-39 |
Renal involvement | 10-75 |
Classic pentad* | 7 |
Laboratory findings | |
Median platelet count, ×109/L | 10-17 |
Median creatinine, μmol/L | 0.96-1.42 |
Median LDH, U/L | 1107-1750 |
Median hematocrit, % | 20-27 |
. | Frequency (%) . |
---|---|
Clinical presentation, % | |
MAHA with thrombocytopenia | 100 |
Neurological abnormalities | 39-80 |
Major | 18-53 |
Minor | 27-42 |
Fever | 10-72 |
Gastrointestinal symptoms | 35-39 |
Renal involvement | 10-75 |
Classic pentad* | 7 |
Laboratory findings | |
Median platelet count, ×109/L | 10-17 |
Median creatinine, μmol/L | 0.96-1.42 |
Median LDH, U/L | 1107-1750 |
Median hematocrit, % | 20-27 |
LDH, lactate dehydrogenase.
MAHA, thrombocytopenia, neurological abnormalities, fever, and renal dysfunction.